Pediatric size phlebotomy tubes and transfusions in adult critically ill patients: a pilot randomized controlled

Javier Barreda Garcia1, Jonathan Z Xian1, Claudia Pedroza2

  • 1Division of Critical Care Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 1.434, Houston, TX 77030 USA.

Insights

Pediatric phlebotomy tubes are acceptable for adult intensive care unit (ICU) patients, potentially reducing red blood cell (RBC) transfusions. Further trials are recommended, especially for patients with lower hemoglobin levels.

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Medical Devices

Background:

  • Red blood cell (RBC) transfusions are common but carry risks and are resource-limited.
  • Reducing iatrogenic blood loss is key to minimizing transfusions.
  • Pediatric phlebotomy tubes were investigated as an intervention to reduce blood loss in critically ill adults.

Purpose of the Study:

  • To assess the feasibility and acceptability of using pediatric phlebotomy tubes in adult ICU patients.
  • To evaluate the potential effectiveness of pediatric tubes in reducing RBC transfusions.
  • To determine the suitability of patient eligibility criteria for future trials.

Main Methods:

  • A pilot randomized controlled trial was conducted in a university-affiliated ICU.
  • 200 adult patients were randomized to use either pediatric or adult size phlebotomy tubes.
  • Feasibility was assessed by blood test recollections and discontinued use; effectiveness was measured by time to RBC transfusion or hemoglobin below 7 g/dL.

Main Results:

  • Pediatric tubes were found to be acceptable, with infrequent test recollections and no discontinuations.
  • The baseline hemoglobin category was the only factor associated with RBC transfusions.
  • Fewer patients in the pediatric tube group (6%) received RBC transfusions compared to the adult tube group (11%).

Conclusions:

  • Pediatric phlebotomy tubes are acceptable for use in adult ICU patients.
  • The intervention shows potential effectiveness, particularly in patients with baseline hemoglobin levels below 9.5 g/dL.
  • A definitive trial is warranted to confirm these findings.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
526
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
154
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111